Physician profile
James Jay Kempiners
NPI 1598842213
$7,014.63
in general payments reported to CMS, 2019-2025
22 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,147 · 2020: $54.19 · 2021: $183 · 2022: $680 · 2023: $388 · 2024: $369 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,720.96 | 2019-2024 | |
| Stryker Corporation | $764.60 | 2019-2025 | Scopis Ent |
| Acclarent, INC | $631.61 | 2019-2022 | |
| Genzyme Corporation | $170.29 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $134.35 | 2019-2024 | Dupixent |
| Alk-Abello, INC | $106.67 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Smith+Nephew, INC. | $91.26 | 2023-2024 | Tula, Halo |
| Glaxosmithkline, LLC. | $62.68 | 2023-2024 | Nucala |
| Medtronic, INC. | $54.94 | 2023-2024 | Pteye Parathyroid Detection System, Propel |
| Aroa Biosurgery Incorporated | $50.38 | 2022 | |
| Ethicon US, LLC | $28.40 | 2019 | |
| Checkpoint Surgical, INC | $28.09 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.49 | 2023 | Cuvitru |
| Genentech USA, INC. | $21.48 | 2023 | Xolair |
| Baxter Healthcare | $20.73 | 2024 | Perclot |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $17.66 | 2023 | Privigen |
| Grifols USA, LLC | $17.66 | 2023 | Xembify |
| Novartis Pharmaceuticals Corporation | $16.82 | 2019 | |
| Hikma Pharmaceuticals USA | $14.01 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.00 | 2019 | |
| Intersect Ent, INC. | $12.57 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kempiners listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.